Explore 3 Stock Ideas & Industry Insights Download Free Report

Healthcare

Medicus Pharma (NASDAQ:MDCX) Penny Stock Extends a Long Decline

● Medicus Pharma shares drifted from above a dollar early in 2026 to about ten cents.

Nitish Kishor | 09 October 2026

Mobile-Health Network Solutions (NASDAQ:MNDR) Penny Stock Plunges in a Thin-Float Session

● The company implemented a one for sixReverse Stock Spliteffective in late June 2026.

Nitish Kishor | 09 October 2026

NewGenIvf Group (NASDAQ:NIVF) Penny Stock Drops Sharply at a Few Cents a Share

● NewGenIvf Group is a company in assisted reproduction and fertility services with a US listing.

Nitish Kishor | 09 October 2026

Sunshine Biopharma (NASDAQ:SBFM) Penny Stock Tumbles Amid a History of Equity Raises

● Sunshine Biopharma has a history of raisingCapitalthrough public and registered directEquityofferings.

Nitish Kishor | 09 October 2026

China SXT Pharmaceuticals (NASDAQ:SXTC) Penny Stock Plunges After Announcing a Direct Offering

● SXTC shares plunged 87.86% to $0.34 in Thursday’s October 8 session, far outside ordinary volatility.

Nitish Kishor | 09 October 2026

Haemonetics (NYSE:HAE) Surges on CSL Plasma Deployment Update and a Citi Target Raise

● CSL committed to a full US deployment of Haemonetics plasma-collection equipment, with a rollout framed around 2027.

Nitish Kishor | 09 October 2026

Veradermics (NYSE:MANE) Stock Rallies in a Thinly Traded Session

● TheNasdaqComposite fell 1.25%, the S&P 500 slipped 0.47%, and the Dow edged up 0.10%.

Nitish Kishor | 09 October 2026

DataMEDS AI (NASDAQ:MEDS) Rallies as Speculative AI Micro-Caps Defy the Tape

● TheNasdaqComposite fell roughly 1.25% as a selloff hit semiconductors and large-cap technology shares.

Nitish Kishor | 09 October 2026

Onconetix (NASDAQ:ONCO) Climbs as Nano-Cap Biotech Draws Momentum Buyers

● ONCO shares rose 9.56% to $0.65 in Thursday’s October 8 session, trading between $0.60 and $0.86 onVolumeof 46.50M shares.

Nitish Kishor | 09 October 2026

Why Did Pacira BioSciences (NASDAQ:PCRX) Stock Soar? The Viatris Takeover Deal

● Viatris agreed to acquire Pacira BioSciences for about $1.65 billion.

Nitish Kishor | 09 October 2026
Support

Hi! How can we help you today?

Loading…